Selexipag is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension
This product will be manufactured at Lupin’s Pithampur facility in India
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
This is the first peptide product approval from the USFDA received by Alembic Pharmaceuticals
Jubilant's Radiopharma Business to expand positron emission tomography radiopharmacy network
As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore
Subscribe To Our Newsletter & Stay Updated
